Animals ; Child ; China ; Dairy Products ; Diet ; Health Promotion ; methods ; Health Status ; Humans ; Nutritional Status ; Nutritive Value

Nonclinical evaluation of vaccines is an important part of innovative vaccine research and development. Information on vaccine efficacy and safety is obtained through nonclinical research to support the clinical development and licensure of the vaccine. In this paper, combined with existing vaccine evaluation experience, the strategies, considerations and concerns of vaccine nonclinical evaluation are summarized by consulting the relevant domestic and foreign literature and guidelines of vaccine nonclinical evaluation in recent years, so as to provide a reference for vaccine researchers. Because of the different characteristics and concerns of therapeutic vaccines, the discussion in this paper mainly focuses on innovative preventive vaccines.

Purpose:To compare old and new clinical staging of primary liver cancre. Methods:317 cases of primary liver cancer(PLC) patients,hospita lized and dead,were investigated retrospectively for overall median survival and survival after various therapies,according to various stages,and therapies and comparison among groups and test of median survival were carried out. Results:Survival in patients with new stage Ⅱa+Ⅱb or old Ⅱw ere significantly longer than newⅢa+Ⅲb or oldⅢ, but no significant differenc es were observed between new stageⅡa+Ⅱb and oldⅡ , or new stage Ⅲa+Ⅲb and oldⅢ. Median survival by new staging , decreased in peoper order from stageⅡ a ,Ⅱb , Ⅲa to Ⅲb respectively, significant different was found only between s tage Ⅲa and Ⅲb but not betweenⅡa andⅡb . Survival decreased respectively fr om interventional treatment ,systemic chemotherapy and palliative therapy;the in terventional treatment group did much better than the palliative group but no si milar differences were observed in the other groups. Conclusions:New clinical staging of PLC did not show significan t superiorly over the old one as judged by median survival.It can be questioned whether basing on largest diameter is less than 5/10 cm or more than 10 cm to di stinguish Ⅱa and Ⅱb is valid.Interventional treatment should be applied as soo n as possible to prolong survival whether it be the new or old clinical staging.

OBJECTIVE To monitor the use and return of disposable infusion device or injector.METHODS To make use of Microsoft Excel,design an applied software dealing with data input,formula edit,statistics calculation and analysis,and how to apply the software were introduced.RESULTS The information of the use and return of disposable infusion device or injector was automatically managed.Working efficiency was greatly improved.CONCLUSIONS The use and return of disposable infusion device or injector are effectively supervised since Microsoft Excel software is applied.

Objective To evaluate the mid-long term effects of hysteroscopic treatment of abnormal uterine bleeding(AUB).Methods A total of 432 patients admitted from January 2002 to November 2005 with AUB were treated with hysteroscopy.All the patients were followed for at least 12 months.Among the 432 patients,391 were diagnosed as having benign lesions,including endometrial polyp in 96 patients(22.2%),submucous myoma in 38 patients(8.8%),and endometrial hyperplasia in 257 patients(59.5%),receiving transcervical myoma resection or transcervical endometrium resection.The other 41 patients were diagnosed as having stage Ⅰ endometrial carcinoma,and a total hysterectomy and bilateral adnexectomy with selective pelvic lymphadenectomy was performed.Results All the operations were successfully completed,without uterine perforation or other complications.During a follow-up of 12～57 months(mean,39 months) in the 391 patients with benign lesions,amenorrhea was found in 63 patients(16.1%,63/391),hypomenorrhea( 1.5 cm in 8 patients,and a second hysteroscopic endometrial resection was given at 5～19 months after first operation.All the 8 patients were further followed for 18～36 months,with findings of amenorrhea in 5 of them and hypomenorrhea in 3.All the 41 patients with stage Ⅰ endometrial carcinoma survived without recurrence during a follow-up period for 26～41 months(mean,38 months).Conclusions Hysteroscopic treatment can be the first choice for treating non-malignant AUB.Pre-operational pathological examination and ultrasonography can enhance the safety and efficacy of the operation.

Objective To evaluate the mid-long term effects of laparoscopic treatment of ovarian endometriosis cysts.Methods Clinical data of 209 cases of ovarian endometriosis cysts treated by laparoscopic operation from January 2002 to December 2005 were retrospectively analyzed.All the patients were followed for at least 12 months(12-54 months).There were 115 cases of unilateral ovarian cyst enucleation,62 cases of bilateral enucleation,11 cases of unilateral adnexectomy,and 21 cases of unilateral adnexectomy combined with contralateral cyst enucleation.Oral gestrinone was administrated in patients without childbearing intentions,while in patients demanding a child,no drug was given and an early pregnancy was encouraged.Results Conversions to open surgery were required in 7 cases.No complications occurred.Ovarian endometriosis cysts recurred in 17 cases(8.1%),including 7 cases of stage Ⅲendometriosis and 10 cases of stage Ⅳ endometriosis.Of the 35 cases of infertility,intrauterine pregnancy was obtained in 16 cases,with a pregnancy rate of 45.7%.The pregnancy occurred at 4-29 months after operation(within 2 years in 10 cases).Of the 157 cases of dysmenorrhea,a complete relief was achieved in 95 cases(60.5%)and an improvement was obtained in 62 cases(39.5%).Conclusions Laparoscopic treatment is suitable for all stages of ovarian endometriosis cysts.Postoperative drug administration and long-term follow-up are necessary to lower the recurrence rate.

Objective:Reporting a rare case with Kimura's disease and angiolymphoid hyperplasia with eosinophilia (ALHE), who also has nephrotic syndrome resulting from minimal change glomerulopathy. Methods: Histological manifestations, immunohistochemical staining, immunofluorescence staining, and electron microscope were performed. Results: One 37-year-old male patient with recurrent erythra, cutaneous node, painless cervical lymph node enlargement and nephrotic syndrome in 5 years. It's confirmed through biopsies that the subcutaneous node is ALHE, the cervical lymph node is kimura disease, and renal lesion is minimal change glomerulopathy. Conclusion: Kimura disease and ALHE may be different features of the same disease, and may complicate glomerulopathy.

Amyotrophic lateral sclerosis is a chronic neurodegenerative disorder characterized by selective death of motor neurons and progressive paralysis. Many hypotheses have been proposed to explain its pathogenesis. In recent years,one of the most studied hypotheses was the inflammatory response accompanying the motor neuron death. Microglia and its interactions with motor neurons play important roles in the development and progression of the inflammatory responses and the disease itself,which results in different new and potent therapeutic strategies of great clinical value.

After surgical removal of a primary tumor the minimal residual cancer cells (MRCC) and metastases derived thereof are the actual targets for all theraputic approaches. Due to the great sensitivity and PCR-based detection systems, the molecular characterization of MRCC can provide information about their metastatic potential, availability of drug targets, drug sensitivity and development of therapy resistance, which will close the analytical gap between primary disease and the detection of metastases by conventional methods such as imaging procedures, and this will help therapy selection, monitoring of the treatment effects and predicting of the prognosis. Patients will benefit from a individualized therapy in the end.

Diabetic nephropathy is one of the leading causes of the end-stage renal failure, and its major pathologic feature is the renal fibrosis. Transforming growth factor-?_1 is a key factor in the progression of the disease. Two signal pathways, Smads and MAPK following the factor, are closely connected with extracellular matrix accumulation which leads to renal fibrosis. Smads and MAPK also have a cross talk in extracellular matrix accumulation. The relationship between the two signal pathway and ECM accumulation offers us a new therapeutic strategy for renal fibrosis of diabetes.